Improving early intervention for young people with psychosis in Texas
Advancing the Early Psychosis Intervention Network in Texas (EPINET-TX)
This study is working to improve treatment for young people aged 12 to 20 who are experiencing their first episode of psychosis by connecting different support programs in Texas, making sure they get the best care possible, and also helping those who might be dealing with substance use issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-10701700 on NIH RePORTER |
What this research studies
This research focuses on enhancing the treatment of first episode psychosis in adolescents aged 12 to 20 through a coordinated specialty care model. By linking various early psychosis intervention programs across Texas, the project aims to standardize care and improve outcomes for young patients. It utilizes a data informatics system to gather and analyze service and outcome measures, fostering continuous improvement in treatment approaches. The initiative also addresses the common issue of co-occurring substance use, which can complicate recovery and treatment adherence.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 12 to 20 who are experiencing their first episode of psychosis.
Not a fit: Patients who are not within the age range of 12 to 20 or who have not experienced a first episode of psychosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better treatment outcomes and improved quality of life for young individuals experiencing their first episode of psychosis.
How similar studies have performed: Previous research has demonstrated the effectiveness of coordinated specialty care for first episode psychosis, indicating that this approach has shown success in other contexts.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Lopez, Molly a. — University of Texas at Austin
- Study coordinator: Lopez, Molly a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.